Blood levels of transferrin (Tf), a protein that transports iron in the body, may serve as a useful biomarker for…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
The time it takes to diagnose ANCA-associated vasculitis (AAV) may be influenced by disease type, organ involvement, and the…
Although long-term survival for people with eosinophilic granulomatosis with polyangiitis (EGPA) has improved in Japan, the introduction of…
A new prediction tool may help identify which people with ANCA-associated vasculitis (AAV) are at risk of developing venous…
People with ANCA-associated vasculitis (AAV) are more likely to have worse kidney function and related outcomes if their self-targeting…
At diagnosis, half of adults with ANCA-associated vasculitis (AAV) already have signs of interstitial lung disease (ILD), a condition…
Lung complications are common among adults with ANCA-associated vasculitis (AAV), affecting four in five individuals throughout their disease course,…
Adults with ANCA-associated vasculitis (AAV) who test positive for antibodies against the myeloperoxidase (MPO) protein may face cardiovascular events…
Tavneos (avacopan), in combination with standard treatment, induced disease remission within six months in nearly all adults with…
Physicians experienced in treating ANCA-associated vasculitis (AAV) generally agree on which disease manifestations are driven by granulomas, or…